Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors' anticancer efficacy.

Source:http://linkedlifedata.com/resource/pubmed/id/18981735

Download in:

View as

General Info

PMID
18981735